- Home
- CLPT vs CERS Comparison
CLPT vs CERS Comparison
Compare CLPT & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- CERS
- Stock Information
- Founded
- CLPT 1998
- CERS 1991
- Country
- CLPT United States
- CERS United States
- Employees
- CLPT N/A
- CERS N/A
- Industry
- CLPT Medical/Dental Instruments
- CERS EDP Services
- Sector
- CLPT Health Care
- CERS Technology
- Exchange
- CLPT Nasdaq
- CERS Nasdaq
- Market Cap
- CLPT 317.4M
- CERS 265.7M
- IPO Year
- CLPT N/A
- CERS 1997
- Fundamental
- Price
- CLPT $10.00
- CERS $1.27
- Analyst Decision
- CLPT Strong Buy
- CERS Strong Buy
- Analyst Count
- CLPT 3
- CERS 2
- Target Price
- CLPT $27.67
- CERS $3.50
- AVG Volume (30 Days)
- CLPT 363.9K
- CERS 896.8K
- Earning Date
- CLPT 08-12-2025
- CERS 08-05-2025
- Dividend Yield
- CLPT N/A
- CERS N/A
- EPS Growth
- CLPT N/A
- CERS N/A
- EPS
- CLPT N/A
- CERS N/A
- Revenue
- CLPT $32,235,999.00
- CERS $185,144,000.00
- Revenue This Year
- CLPT $23.97
- CERS $24.95
- Revenue Next Year
- CLPT $27.52
- CERS $11.88
- P/E Ratio
- CLPT N/A
- CERS N/A
- Revenue Growth
- CLPT 23.22
- CERS 13.06
- 52 Week Low
- CLPT $6.25
- CERS $1.12
- 52 Week High
- CLPT $19.22
- CERS $2.54
- Technical
- Relative Strength Index (RSI)
- CLPT 33.16
- CERS 39.38
- Support Level
- CLPT $10.47
- CERS $1.34
- Resistance Level
- CLPT $11.07
- CERS $1.41
- Average True Range (ATR)
- CLPT 0.53
- CERS 0.07
- MACD
- CLPT -0.10
- CERS -0.02
- Stochastic Oscillator
- CLPT 2.99
- CERS 6.67
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.